Related Experiment Video

Updated: Sep 30, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Ventricular remodeling and the renin angiotensin aldosterone system

R D Patten1, M A Konstam

  • 1Division of Cardiology, Department of Medicine, New England Medical Center, Boston, MA 02111.

Congestive Heart Failure (Greenwich, Conn.)
|July 31, 2002
PubMed

Insights

The renin-angiotensin-aldosterone system drives ventricular remodeling in systolic dysfunction. Blocking this system, particularly with ACE inhibitors and aldosterone blockers, improves heart failure outcomes.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Ventricular remodeling is a slow process linked to poor prognosis in left ventricular systolic dysfunction.
  • The renin-angiotensin-aldosterone system plays a key role in the development of ventricular remodeling.
  • Heart failure is a syndrome closely related to ventricular remodeling.

Purpose of the Study:

  • To review the role of the renin-angiotensin-aldosterone system in ventricular remodeling.
  • To discuss the impact of ACE inhibitors and angiotensin II type I receptor blockers on remodeling.
  • To highlight the role of aldosterone in interstitial remodeling and its blockade.

Main Methods:

  • Review of clinical and experimental data.
  • Analysis of studies on ACE inhibitors and angiotensin II type I receptor antagonists.
  • Examination of aldosterone's role in interstitial remodeling.

Main Results:

  • ACE inhibitors improve ventricular remodeling and heart failure.
  • Angiotensin II type I receptor blockade shows favorable effects on remodeling.
  • Aldosterone blockade improves clinical outcomes by targeting interstitial remodeling.

Conclusions:

  • The renin-angiotensin-aldosterone system is central to ventricular remodeling in systolic dysfunction.
  • Pharmacological blockade of this system, including aldosterone, offers therapeutic benefits.
  • Further research is needed to fully elucidate mechanisms and develop more effective treatments.

More Related Videos

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...